Skip to content
Dose Brief
Menu

Kina review

By Updated

Kina focuses on midlife weight care and lists ongoing injection prices, but its no-membership offer conflicts with general billing terms.

Brief Score69/100Grade CNo. 176 in our directory
Visit Kina View the provider’s current plans and terms.
Semaglutide

Confirm medication + care total

Injection advertised at $199/mo ongoing. The no-membership offer conflicts with separate-fee language in general terms.

Full price details

Compounded semaglutide offered; complete quote unknown because membership terms conflict; injection advertised $199/month ongoing; earlier listing: From $179/mo (starting dose, plus a separate fee, compounded)

Tirzepatide

Confirm medication + care total

Injection advertised at $249/mo ongoing. The no-membership offer conflicts with separate-fee language in general terms.

Full price details

Compounded tirzepatide offered; complete quote unknown because membership terms conflict; injection advertised $249/month ongoing; earlier listing: From $179/mo (starting dose, compounded)

Coverage
Care depends on clinician and pharmacy licensing in your location; no complete current state roster established
Brand-name
Not confirmed

Prices checked against Kina's published terms in . Providers change pricing without notice — check the current figure before you buy.

On the trackerNewnew to the tracker, no prior reading— Ongoing injections list $199 semaglutide/$249 tirzepatide. Complete totals remain unconfirmed because general terms describe membership and separately billed medication.

Kina in depth

Starting care and ongoing medication prices differ

Kina advertises care from $169 for the first month, while its weight page lists ongoing semaglutide injections at $199 monthly and tirzepatide injections at $249. The introductory figure is a general starting offer, not a verified first-month price for every product. Ask which discount and continuing rate apply to the prescribed formulation.

Oral semaglutide is separately listed at $279 monthly and tirzepatide sublingual drops at $229. Direct Meds also runs an oral and sublingual line alongside injections on both molecules. Those formulations should not be treated as interchangeable alternatives solely on price. The billing guide helps compare supplied quantity, payment interval and follow-up costs once the exact quote is available.

Midlife care and named clinical relationships

The weight-care offer focuses on women in menopause and midlife, with clinician review, ongoing messaging, dose support and shipping. It describes the consultation fee as covered and anti-nausea support for the initial period. Those services remain subject to clinical suitability; the website does not guarantee a prescription or a particular result.

Public sources name Arora Health & Aesthetics for clinical care and Jungle Jim’s Pharmacy in the terms. Confirm the actual treating clinician and dispensing facility using the pharmacy checklist. Availability depends on state-specific licensing. Compounded medications are not FDA-approved, and a named clinical lead’s qualification should not be mistaken for an assigned physician.

Resolve the membership contradiction first

The weight offer says there are no membership fees and describes included care. General terms instead describe recurring memberships with medication and supplements billed separately. That is a material billing conflict, not proof that the advertised injection amount is a confirmed complete total. Obtain the agreement governing weight care before paying.

Terms also make membership fees nonrefundable after clinical review and shipped medication nonrefundable. Pre-review cancellation may qualify for a refund. Ask how those rules apply to a plan advertised without membership fees, and confirm the next renewal date. The refund checklist helps separate stopping future payments from reversing completed care.

Sources we checked

Public program pages and terms, checked November 2026. We have not enrolled in treatment or independently tested the medication.

This source update covers the review text and stated program terms. The existing numerical score has not been recalculated from this check; it should not be read as a new validation of every score factor.

The scorecard

Kina scored on our six Brief Score factors. See the methodology.

Price Stability48/100
Supply Reliability84/100
Transparency72/100
Access Breadth50/100
Clinical Oversight88/100
Track Record80/100

What we like

  • Separates ongoing injection and oral-formulation prices
  • Names its clinical group and pharmacy in legal sources
  • Advertises included clinical support and shipping

The caveats

  • No-membership offer conflicts with separate-fee legal wording
  • Generic introductory price does not apply clearly to every product
  • State eligibility and any additional laboratory costs need confirmation

The brief

Best for: Women seeking midlife-focused clinical support who can confirm the medication, complete bill and applicable cancellation terms. Kina focuses on midlife weight care and lists ongoing injection prices, but its no-membership offer conflicts with general billing terms.

Ranked #176 of 546 providers we reviewed — compare with CoreAge Rx, for comparison.

Before you decide

The questions readers ask next after reading about Kina.

Closest here

The providers scoring nearest Kina — read each current assessment before choosing care.

Weighing Kina against one provider in particular? There is a full head-to-head with our top-ranked pick in CoreAge Rx vs Kina, and every provider that outranks it is listed on the Kina alternatives ranking.

More providers we track (24)

514 more are filed too — see every provider we track, ranked.

Pricing, states and verification reflect Kina's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on Kina's site. Not medical advice; see our disclosure.

← Back to all rankings